Related Experiment Video
Updated: May 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Heart Disease in Older Women: Unique Challenges in Diagnosis and Management
Radmila Lybarova1, Sarah Malik2, Roopa Rao3
1Department of Medicine/Cardiology, Albany Medical College, 43 New Scotland Ave, Albany, NY, US 12208, USA. lyubarr@amc.edu.
Insights
Older women face unique cardiovascular disease challenges, including heart failure with preserved ejection fraction (HFpEF) and coronary microvascular dysfunction. Addressing these requires tailored care and increased clinical trial representation.
Area of Science:
- Cardiology
- Geriatrics
- Women's Health
Background:
- Cardiovascular disease (CVD) presents differently in older women due to aging and hormonal changes.
- Unique pathophysiological mechanisms and clinical manifestations are observed in this demographic.
Purpose of the Study:
- To review age- and sex-specific CVD patterns in older women.
- To clarify the influence of aging and hormonal transitions on CVD presentation and outcomes.
- To identify disparities and gaps in cardiovascular care for older women.
Main Methods:
- This is a review article.
- It synthesizes emerging data and contemporary studies.
- Focuses on pathophysiology, diagnostic challenges, and management disparities.
Main Results:
- Older women are disproportionately affected by heart failure with preserved ejection fraction (HFpEF), coronary microvascular dysfunction, atrial fibrillation, and valvular heart disease.
- Atypical symptoms contribute to diagnostic delays; gaps exist in timely diagnosis, advanced therapy referral, and clinical trial representation.
- Frailty, multimorbidity, and patient-centered care are increasingly recognized.
Conclusions:
- Recognizing age- and sex-specific CVD characteristics is crucial.
- Increasing representation in clinical trials and equitable access to care are vital.
- Aligning treatment with patient priorities will improve outcomes for older women with CVD.
Purpose Of Review:
This review examines the unique cardiovascular disease patterns in older women, focusing on sex and age-specific pathophysiology, diagnostic challenges, and disparities in management. We aim to clarify how aging and hormonal transitions influence disease presentation and outcomes among women, and to identify gaps in cardiovascular care.
Recent Findings:
Emerging data demonstrate that older women are disproportionately affected by HFpEF, coronary microvascular dysfunction, atrial fibrillation, and valvular heart disease. These conditions are influenced by vascular stiffness, myocardial remodeling, and systemic inflammation and often present with atypical symptoms leading to diagnosis delays. Contemporary studies highlight persistent gaps in timely diagnosis, referral for advanced therapies, and representation in clinical trials. Increasing attention is being directed toward frailty, multimorbidity, and patient-centered care models in this population. Recognizing age and sex-specific characteristics, increasing representation of older women in clinical trials, improving equitable access to diagnostic and therapeutic resources, and aligning treatment decisions with patient priorities are critical to narrowing existing gaps and improving long-term outcomes for older women with cardiovascular disease.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management